ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Time-Multiplexed Organic Electrochemical Transistor for Saliva-Based Rapid Detection of Viral Proteins.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Timely and accurate diagnosis of respiratory infections is complicated by the symptomatic overlap between highly transmissible pathogens such as respiratory syncytial virus (RSV), influenza A (IAV), and influenza B (IBV), highlighting the need for rapid and reliable diagnostics. Here, we report a time-multiplexed nanobody-functionalized organic electrochemical transistor (OECT) biosensor for the sensitive detection of RSV, IAV, and IBV directly from unprocessed saliva samples. The platform integrates arrays of nanobody-functionalized gate electrodes that are exposed in parallel to a single sample and sequentially addressed through a shared transistor channel. We characterize nine previously reported nanobodies and immobilize the best-performing ones using an oriented SpyDirect self-assembly strategy. The nanobody-functionalized gate electrodes are paired with a high-performance p-type organic mixed ionic-electronic conductor channel, enabling efficient signal transduction. The sensor achieves a limit of detection of ca. 1 fm and identifies viral targets within 15 min, without sample preprocessing. In a clinical validation using 17 samples, the platform demonstrated 100% specificity, 86.7% sensitivity, and 88.2% overall accuracy. By combining highly specific nanobodies, a high-gain transducer, customized surface pre-treatment, and a time-multiplexed multi-gate architecture, this approach provides a scalable and user-friendly platform for point-of-care virus detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.